Hi WAG, I get your reticence, I’m sure most here have been bitten before by a stock that has tanked for any reason but offer the following. NEU has an FDA approved treatment for one disorder that’s been licensed out and is generating ongoing revenue that is providing the company with ongoing profit, we have the same product who’s use can be expanded to provide increased profit to NEU. We have another product that has proven efficacy in numerous indications and has passed 3 P2 trials and is preparing for a final P3 trial. Finally Jon has expanded on the reasons for the SBB very well; I believe it will be ultra successful due to tho low SOI and little stock for sale, just look at the sell depth this morning, I know there are constraints on what they’re allowed but the clock is ticking, 5 trading days to go for the shorts to cover.
NEU Price at posting:
$12.36 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)